Aastrom places clinical hold on Phase II heart failure trial Pharmaceutical Business Review - IMPACT-DCM is the first clinical trial in the US to evaluate the surgical delivery of autologous cells directly into the human heart muscle for the ... |
« CSC Signs Five-year BPO Services Extension with Aspen Valley Hospital - HealthNEWS. Direct! | Main | Crucell Announces Profits for Full Year 2008 - CNNMoney.com »
TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00e54ed2f12088330112790d65c628a4
Listed below are links to weblogs that reference Aastrom places clinical hold on Phase II heart failure trial - Pharmaceutical Business Review:
This is only a preview. Your comment has not yet been posted.
As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.
Having trouble reading this image? View an alternate.
Comments